Reilly John Charles
Transaction: 06/18/2026
SELL
Change
-700
Price
$5.21
Filing
06/22/2026
Type
SELL
Talkspace, Inc.
TALK • Medical - Care Facilities
$5.25
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$879.30M
Growth
29.7%
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 16.5%Manageable debt level · 0Healthy liquidity · 6.38Expensive earnings multiple · 78.45
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:16 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$5.25
Change0.00%
Shares Out167.49M
Market Cap$879.30M
Enterprise Value$788.30M
52W Range2.39 - 5.25
Beta1.07
P/E4,532.48
P/S3.58
P/B7.84
P/FCF-5,565.20
EV/Sales3.21
Price$5.25
Change0.00%
Shares Out167.49M
Market Cap$879.30M
Enterprise Value$788.30M
52W Range2.39 - 5.25
Beta1.07
P/E4,532.48
P/S3.58
P/B7.84
P/FCF-5,565.20
EV/Sales3.21
EV/EBITDA130.95
EV/FCF-4,989.26
Earnings Yield0.02%
FCF Yield-0.02%
Dividend Yield0.00%
Gross Margin42.97%
Oper. Margin1.38%
Profit Margin3.40%
Debt/Eq0.00
Current Ratio6.38
Quick Ratio6.38
Revenue 5Y29.68%
Target$5.25
Target Upside0.00%
Target Median$5.25
Target Range5.25 - 5.25
Volume599.55K
Avg Volume1.89M
EPS Surprise-0.06
Investment DNA
How strong this company looks for long-term investors
51
out of 100
Business Quality
Margins, moat, returns
41/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
45/100
Why this score▼
Positive revenue growth · 16.5%Manageable debt level · 0Healthy liquidity · 6.38Expensive earnings multiple · 78.45
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 10 analyst votes · 2026-09-05
60/100
Neutral
Bullish
2
Hold
8
Bearish
0
Price Target
2026-08-07
Low
$5.25
Mean
$5.25
Median
$5.25
High
$5.25
Insider Transactions
Recent executive and insider activity
Harris Ian Jiro
Transaction: 06/12/2026
SELL
Change
-38,561
Price
$5.23
Filing
06/16/2026
Type
SELL
Watson Katelyn
Transaction: 06/12/2026
SELL
Change
-7,181
Price
$5.23
Filing
06/16/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Reilly John Charles | SELL | -700 | $5.21 | 06/18/2026 | 06/22/2026 |
| Harris Ian Jiro | SELL | -38,561 | $5.23 | 06/12/2026 | 06/16/2026 |
| Watson Katelyn | SELL | -7,181 | $5.23 | 06/12/2026 | 06/16/2026 |
| Cohen Jon R | SELL | -99,720 | $5.23 | 06/12/2026 | 06/16/2026 |
| Reilly John Charles | SELL | -54,244 | $5.21 | 06/12/2026 | 06/16/2026 |
| Pawar Madhu | BUY | +1,922 | Not reported | 06/01/2026 | 06/03/2026 |
| Braunstein Douglas L | BUY | +3,363 | Not reported | 06/01/2026 | 06/03/2026 |
| Shachar Erez | BUY | +2,402 | Not reported | 06/01/2026 | 06/03/2026 |
| Reilly John Charles | BUY | +92,108 | Not reported | 03/31/2026 | 04/06/2026 |
| Watson Katelyn | BUY | +38,783 | Not reported | 03/31/2026 | 04/06/2026 |
| Harris Ian Jiro | BUY | +145,434 | Not reported | 03/31/2026 | 04/06/2026 |
| Margolin Gil | BUY | +58,174 | Not reported | 03/31/2026 | 04/06/2026 |
| Cohen Jon R | BUY | +387,823 | Not reported | 03/31/2026 | 04/06/2026 |
| Watson Katelyn | SELL | -1,598 | $4.82 | 03/13/2026 | 03/16/2026 |
| Shachar Erez | BUY | +2,684 | Not reported | 03/01/2026 | 03/03/2026 |
| Braunstein Douglas L | BUY | +3,757 | Not reported | 03/01/2026 | 03/03/2026 |
| Pawar Madhu | BUY | +2,147 | Not reported | 03/01/2026 | 03/03/2026 |
| Watson Katelyn | SELL | -12,148 | $4.04 | 02/12/2026 | 02/20/2026 |
| Reilly John Charles | BUY | +20,542 | Not reported | 01/30/2026 | 02/04/2026 |
| Cohen Jon R | BUY | +74,695 | Not reported | 01/30/2026 | 02/02/2026 |